Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 294-785-9 | CAS number: 91770-03-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
The toxicokinetic profile of the test item was predicted using the physical chemical properties of the substance, the data obtained from acute and repeated-dose toxicity studies, as well as information gained from genotoxicity assays.
Physico-chemical properties
The substance is a UVCB with an average molecular weight of 669 g/moL. The substance is poorly water soluble, < 4.93 mg/L from the results of an OECD 105 study (considered to be an over-estimate for various technical reasons), with a relative high octanol/water partition coefficient, log Pow 11.7 (which is > 4, the bioaccumulation limit), and a very low vapour pressure (3.5 x 10E-04 Pa at 25 °C).
Absorption
Oral Route
The physical chemical properties described above indicate that the substance has a molecular size (MW > 500, notable percentage > 1000) greater than that which may be expected to be easily absorbed within the mammalian gastrointestinal tract, should that material be ingested. Being highly lipophilic but with a Log Pow > 11 (log Pow = 11.7), the substance may be expected not to cross gastrointestinal epithelial barriers, and the high MW may also significantly restrict absorption, at least of a major proportion of this UVCB. It may also participate in micellar transport into the hepatic portal system along with other lipophilic substances (e.g., dietary fats). However, an acute oral gavage toxicity study identified no evidence of toxicity (LD50 > 5000 mg/kg bw). The repeat dose and the one- generation reproductive toxicology using the oral route gave a NOAEL of 1000 mg/kg bw/day and a 90-day repeat dose toxicology study indicated a NOAEL = 250 mg/kg bw/day (the adverse effects, such as centrilobular hepatocyte enlargement in females and sinus histiocytosis of the mesenteric lymph nodes of both sexes at 1000 mg/kg bw/day were considered of low toxicological concern). The lack of significant adverse findings following oral dosing may be due to limited gastrointestinal absorption of the test material after dosing, or a very low index of inherent toxicity for this substance, and/or its metabolite(s). However, the observation of systemic effects, even if minor in nature, indicates the potential for absorption of the test item, or its metabolites, or at least some components of this UVCB substance. There is some evidence that the substance readily hydrolyses, which may occur at the amide link producing an acid and a primary amine. Depending on the MW, these could be absorbed more easily than the parent molecules.
Dermal Route
Regarding the dermal absorption of the substance, its rate of uptake into the stratum corneum and its rate of transfer between the stratum corneum and the epidermis are likely to be slow considering both the high MW (>500 g/mol) and the log Pow value (11.7). Moreover, it is assumed that the dermal uptake of the test item is also limited based on its low water solubility (<4.93 mg/L). These assumptions were supported by the absence of observed systemic effects following dermal application of the substance in both the acute toxicity study at up to 2000 mg/kg bw and in the 28-day repeat dose toxicity study at up to 1000 mg/kg bw/day, which is considered as the NOEL.
Inhalation Route
The potential for inhalation toxicity was not studied directly in a toxicology study using the inhalation route. However, the low vapour pressure of the substance (3.5 x 10E-04 Pa) indicates a very low propensity to enter atmospheric air in a respirable form. Thus, respiratory absorption under normal use and handling of this material is expected to be inconsequential. The substance is used as a component in metal working fluids and as a consequence there is a potential for exposure via the production of aerosols. In this case the absorption across the respiratory epithelium is likely to be low, because of the physicochemical properties discussed previously, and hydrolysis in the aqueous environment of the respiratory system may also occur. For route-to-route extrapolation purposes (oral-to-inhalation extrapolation), it is proposed to include a default factor of 2, i.e. the absorption percentage by oral route is half that of the inhalation absorption.
Distribution
Systemic distribution of the test item can be predicted from the physical chemical properties of this substance. The relatively high log Pow and poor water solubility suggests that this substance, upon systemic absorption, may be transported through the circulatory system in association with a carrier molecule such as a lipoprotein or other macromolecule. The lipophilic character but high Log Pow > 11 (Log Pow 11.7) and high MW of the substance suggests that a major proportion of the substance will not readily traverse cellular barriers or distribute into fatty tissues. There is no evidence such as significant systemic toxicity and/or histopathological changes or increasing severity of clinical observations from repeated dose studies, of cumulative toxicity, as would be manifested by an accumulation of the test item or metabolites in tissues. There is evidence that the substance readily hydrolyses, which may facilitate distribution.
Metabolism
The test item is a UVCB. Like most xenobiotics, the substance may be expected to undergo phase I oxidation/reduction, esterase-catalyzed hydrolysis and subsequent Phase II conjugation. Acute and repeated-dose toxicity testing provided no evidence that the substance was metabolized into toxic metabolites. Data from bacteria mutagenicity and chromosomal aberration in mammalian cells, in which the substance was subjected to rat hepatic microsomal enzyme systems didn’t show any evidence of genotoxic activity from the substance or its metabolites. Furthermore, the in vitro toxicity of the test item was reduced in the presence of metabolic enzymes. This may indicate that the metabolites may be less toxic than the substance itself or that the presence of protein may bind the substance such that the toxicity is reduced.
Excretion
The structural characteristics (the amide link and borate moiety are the probable sites in the chemical structure that are susceptible to hydrolysis) of the substance suggest that this molecule may readily undergo phase I and phase II metabolic transformation. The resulting metabolic by-products are expected to undergo routine renal and or biliary excretion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.